ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and ...

产品名称： iFluor 549重组抗小鼠 CD19 单克隆抗体 (克隆号1D3) | 悉得（Syd Labs） PA007374 英文名： iFluor 549 Recombinant Anti-mouse CD19 Monoclonal ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

SAN DIEGO, CA, USA I 18, 2024 I Capstan Therapeutics, Inc. (“Capstan”), a biotechnology company dedicated to advancing in vivo reprogramming of cells ...

Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...

It should also be noted that Amgen's anti-CD19 monoclonal antibody Uplinza (inebilizumab), which is administered once every six months after two initial doses 15 days apart, demonstrated a 1.9 ...

Finally, Dr Narayanaswami examines results for inebilizumab, a first-in-class anti-CD19 B cell–depleting agent. The drug demonstrated safety and beneficial efficacy compared with placebo in ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

In a remarkable New York Times op-ed published on April 4, 2016, Vance provocatively argued that “Trump’s anti-war message resonates with white America.” Vance’s insight then prefigures ...

There has been a 112% increase in documented attacks on LGBTQ+ people nationwide, according to a newly unveiled Anti-LGBTQ Extremism Reporting Tracker (ALERT) from the queer media watchdog ...